Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
1,104.101,103.921,108.751,097.16
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
604.16604.16610.19604.12
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
1,197.811,200.581,213.071,192.02
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
1,740.411,739.551,750.271,730.60
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
634.44633.13639.87633.01
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
840.90839.53841.73831.10
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
215.13215.13215.85213.24
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
3,228.713,225.623,235.433,198.95
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
935.87938.37942.00935.65
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
1,457.121,452.741,466.881,449.18
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
2,399.842,389.712,394.612,371.22
VNDA:NASDAQ
Vanda Pharmaceuticals Inc.
$6.79
-1.45%
(-0.100) 1D
$6.79
0.00% (0.00)
After hours
Closed: Apr 27, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VNDA...
Open
$6.89
High
$7.18
Low
$6.77
Mkt. cap
408.32M
Avg. vol.
1.69M
Volume
6.00
52-wk high
$9.94
52-wk low
$3.81
EPS
-$3.74
Beta
0.71
Shares outstanding
59.11M
No. of employees
533
News stories
From sources across the web
About Vanda Pharmaceuticals Inc.
CEO-
Employees533
Founded2002
HeadquartersWashington, Washington, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
50.04M
52.59M
56.26M
57.22M
Cost of goods sold
3.52M
2.74M
2.95M
3.83M
Cost of revenue
3.52M
2.74M
2.95M
3.83M
Research and development expenses
35.71M
21.99M
22.56M
29.01M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
50.08M
64.62M
60.27M
62.98M
Operating expense
87.55M
88.36M
84.59M
93.74M
Total operating expenses
91.07M
91.09M
87.54M
97.57M
Operating income
-41.03M
-38.50M
-31.28M
-40.35M
Other non operating income
-
-
-
-
EBT including unusual items
-37.37M
-34.89M
-28.39M
-38.00M
EBT excluding unusual items
-37.37M
-34.89M
-28.39M
-40.06M
Income tax expense
-7.87M
-7.68M
-5.80M
103.18M
Effective tax rate
21.07%
22.01%
20.44%
-271.53%
Other operating expenses
-
-
-
-
Net income
-29.49M
-27.21M
-22.59M
-141.19M
Net profit margin
-58.94%
-51.73%
-40.15%
-246.76%
Earnings per share
-
-
-
-
Interest and investment income
3.66M
3.62M
2.89M
298.00K
Interest expense
-
-
-
-
Net interest expenses
3.66M
3.62M
2.89M
298.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-39.04M
-36.48M
-29.23M
-38.30M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more